Trichomegaly of the eyelashes after lung cancer treatment with the epidermal growth factor receptor inhibitor erlotinib

J Clin Oncol. 2008 Jul 10;26(20):3460-2. doi: 10.1200/JCO.2008.16.9391.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Biopsy, Fine-Needle
  • Brain Neoplasms / drug therapy*
  • Brain Neoplasms / secondary
  • Carcinoma, Bronchogenic / drug therapy*
  • Carcinoma, Bronchogenic / pathology
  • Carcinoma, Bronchogenic / radiotherapy
  • ErbB Receptors / antagonists & inhibitors
  • Erlotinib Hydrochloride
  • Eyelashes / drug effects*
  • Female
  • Follow-Up Studies
  • Humans
  • Hypertrichosis / chemically induced*
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / pathology
  • Lung Neoplasms / radiotherapy
  • Magnetic Resonance Imaging
  • Middle Aged
  • Neoplasm Invasiveness / pathology
  • Neoplasm Staging
  • Quinazolines / adverse effects*
  • Quinazolines / therapeutic use
  • Risk Assessment

Substances

  • Quinazolines
  • Erlotinib Hydrochloride
  • ErbB Receptors